Keratins in colorectal epithelial function and disease

Summary Keratins are the largest subgroup of intermediate filament proteins, which are an important constituent of the cellular cytoskeleton. The principally expressed keratins ( K ) of the intestinal epithelium are K 8, K 18 and K 19. The specific keratin profile of a particular epithelium provides it with strength and integrity. In the colon, keratins have been shown to regulate electrolyte transport, likely by targeting ion transporters to their correct location in the colonocytes. Keratins are highly dynamic and are subject to post‐translational modifications including phosphorylation, acetylation and glycosylation. These affect the filament dynamics and hence solubility of keratins and may contribute to protection against degradation. Keratin null mice ( K 8 −/− ) develop colitis, and abnormal keratin mutations have been shown to be associated with inflammatory bowel disease ( IBD ). Abnormal expression of K 7 and K 20 has been noted in colitis‐associated dysplasia and cancers. In sporadic colorectal cancers ( CRC s) may be useful in predicting tumour prognosis; a low K 20 expression is noted in CRCs with high microsatellite instability; and keratins have been noted as dysregulated in peri‐adenomatous fields. Caspase‐cleaved fragment of K 18 ( M 30) in the serum of patients with CRC has been used as a marker of cancer load and to assess response to therapy. These data suggest an emerging importance of keratins in maintaining normal function of the gastrointestinal epithelium as well as being a marker of various colorectal diseases. This review will primarily focus on the biology of these proteins, physiological functions and alterations in IBD and CRC s.